OnFolio enters LOI to acquire Paramount Helium in 50M share deal
OnFolio Holdings entered a binding letter of intent to acquire Paramount Helium in a merger. The deal involves issuing approximately 50 million shares of common stock.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
OnFolio Holdings entered a binding letter of intent to acquire Paramount Helium in a merger. The deal involves issuing approximately 50 million shares of common stock.
Institutional holdings report (13F-HR) filed by Mirabaud & Cie SA.
Institutional holdings report (13F-HR) filed by Mallini Complete Financial Planning LLC.
Fusemachines confirmed it regained Nasdaq compliance with its minimum market value rule on July 7, 2026, allowing for continued listing. This notice resolves past delisting concern…
GMR Solutions Inc. appointed healthcare leaders Dr. Amar Desai and Ellen Zane to its Board of Directors, effective July 1, 2026. This expansion is expected to bolster the company's…
Net sales grew 6% and Enerpac announced a definitive agreement to acquire SFE Group in Q3 Fiscal 2026. The announcement supported updated fiscal guidance and reflected strong opera…
Translational Development Acquisition Corp. noted that ProLogium filed an initial Form F-4 with the SEC to support the de-SPAC merger announced on May 27. This regulatory filing in…
Institutional holdings report (13F-HR) filed by PensionDanmark Pensionsforsikringsaktieselskab.
Azenta Germany GmbH amended the B Medical Systems SPA to include a vendor loan worth $35 million. This adjustment primarily impacts the cash flow timing for the buyer, Thelema.
LM Funding America produced 8.7 Bitcoin in June 2026, lower than May's figures due to higher temperatures. The company's treasury of 318.3 BTC is valued at $18.6 million based on t…
Institutional holdings report (13F-HR) filed by PensionDanmark Pensionsforsikringsaktieselskab.
Navitas Semiconductor disputes baseless patent infringement allegations filed by Wolfspeed in Delaware federal court. The company asserts it expects to prevail while remaining focu…
Company generated $2.58M in revenues driven by sales of allogenic biologic products, while reducing its net loss to approximately $1.0M.
Institutional holdings report (13F-HR) filed by Czech National Bank.
Institutional holdings report (13F-HR) filed by Luma Capital S.A. - SPF.
Institutional holdings report (13F-HR) filed by PensionDanmark Pensionsforsikringsaktieselskab.
Institutional holdings report (13F-HR) filed by Shearwater Capital LLC.
Institutional holdings report (13F-HR) filed by 13F-HR/A - WELLS FARGO & COMPANY/MN (0000072971) (Filer).
Aura Biosciences filed an amended director compensation policy effective upon the IPO registration statement's effectiveness. The policy sets new cash retainers and equity grants t…
Keenova Therapeutics announced positive results from a Phase 3 clinical trial for XIAFLEX, demonstrating significant pain relief and functional improvement. The company plans to su…